Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects.
- 1 January 2001
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 17 (2) , 135-140
- https://doi.org/10.1023/a:1017919305501
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Development of an Adjuvant to Enhance the Immune Response to Influenza Vaccine in the ElderlyBiologicals, 1997
- Effectiveness of Influenza Vaccine in the ElderlyGerontology, 1996
- Health Impact of Influenza in the United StatesPharmacoEconomics, 1996
- The Clinical Efficacy of Influenza VaccinationPharmacoEconomics, 1996
- Immunogenicity of an Inactivated Split Influenza Vaccine in Institutionalized Elderly PatientsGerontology, 1996
- Influenza Vaccination in Older PatientsDrugs & Aging, 1995
- Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adultsVaccine, 1995
- Adjuvants for human vaccines—current status, problems and future prospectsVaccine, 1995
- Adjuvant effect of low-dose interleukin-2 on antibody response to influenza virus vaccination in healthy elderly subjectsMechanisms of Ageing and Development, 1994
- Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responsesVaccine, 1990